Insider Cluster (2 insiders) ·Filed Jul 1, 2026

BEAM

Beam Therapeutics Inc.
BEARISH
Impact 4/10
Horizondays Processed3mo ago
Insider cluster: 2 insiders, $9.3M total
Actionable Insight ▼ Bearish

Monitor for additional insider sales or changes in institutional ownership. The large FMR sale may signal reduced conviction, but CEO option-related sales are routine. Watch next 10-Q for any operational updates.

DirectionBearish
Confidencemedium
Horizondays
Final — all horizons settled through T+60d
BEAM ▼ -26.34% at T+60d
SHORT call ✓ call won +26.34% · α vs SPY +29.30% · entry $33.48 → $24.66
Entry anchored
Jun 30, 03:59 PM ET
via exchange tick
T+1d
+3.91%
call -3.91% · α -4.04%
$34.79
settled 3mo ago
T+5d
+13.26%
call -13.26% · α -13.00%
$37.92
settled 3mo ago
T+20d
-22.28%
call +22.28% · α +20.10%
$26.02
settled 2mo ago
T+60d
-26.34%
call +26.34% · α +29.30%
$24.66
settled 8d ago

Price Chart

Loading chart...

Executive Summary

CEO John M. Evans exercised options and sold shares worth ~$1.26M, while 10% owner FMR LLC sold 251,488 shares (~$8.87M) in a cluster sale totaling $9.34M, representing ~0.27% of BEAM's $3.4B market cap. The CEO's sales are likely liquidity-related from option exercises, but the large FMR block sale adds bearish pressure.

Key Financial Metrics

Direction
selling
Total Value
$9.3M
Insiders
2

Key Facts

  • CEO Evans sold 36,521 shares (post-exercise) for ~$1.26M between June 26-30, 2026
  • FMR LLC (10% owner) sold 251,488 shares for ~$8.87M on June 26, 2026
  • Total insider cluster sales: $9.34M, or 0.27% of market cap
  • All CEO sales followed option exercises (non-cash acquisitions)

Financial Impact

Insider selling of $9.34M is modest relative to $3.4B market cap

insider selling volume

Risk Factors

  • Further insider selling could pressure the stock
  • Large 10% owner sale may precede additional distribution

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
88% bullish (25 analysts)

Investment Themes

Biotech & Drug DiscoveryGenomics & Gene Editing

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-BEAM-1782977373165
7 reports for BEAM
Performance horizon
100% Hit rate 3 of 3 directional calls best @ T+60▲ +53.81%Mar 25, 2026
Filters
Rows
Reports for BEAM — sortable, filterable
TypeNow
Aug 15, 2026
6w ago
Institutional Cluster
BULLISH ★ 5/10
$27.10 $23.22▼ −14.32%▼ −12.34%$24.50 (−9.59%)
Jul 2, 2026
13w ago
Insider Cluster
MIXED ★ 5/10
$34.79 $26.49▼ −23.86%▼ −23.44%$24.50 (−29.58%)
Jul 1, 2026
13w ago
Insider Cluster
BEARISH ★ 4/10
$33.48 $26.02▲ +22.28%▲ +20.10%$24.50 (+26.82%)
May 12, 2026
20w ago
Press Release
BULLISH ★ 7/10
$31.58 $29.49▼ −6.62%▼ −4.89%$24.50 (−22.42%)
Apr 17, 2026
24w ago
DEFA14A
NEUTRAL ★ 3/10
$31.19 $26.81▼ −14.04%▼ −18.25%$24.50 (−21.45%)
Mar 25, 2026
27w ago
Press Release
BULLISH ★ 8/10
$23.12 $30.16▲ +30.45%▲ +22.59%$24.50 (+5.97%)
Mar 5, 2026
30w ago
8-K
NEUTRAL ★ 4/10
$26.54 $24.23▼ −8.70%▼ −6.66%$24.50 (−7.69%)
Showing 7 of 7

US Market Status

Market Closed — Opens Mon (38h 33m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Jul 2, 2026